芳香酶(ARO)多克隆抗體
Polyclonal Antibody to Aromatase (ARO)
CYP19A1; CYPXIX; ARO; ARO1; CPV1; CYAR; CYP19; P450AROM; P450-AROM; Estrogen synthase; Cytochrome P450,Family 19,Subfamily A,Polypeptide 1
- 編號PAC319Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPC319Mu01-芳香酶(ARO)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 666¥ 1554¥ 2220¥ 5550¥ 22200
- 欲了解實際交易價格和更多情況，請與當地經銷商聯(lián)系!
產品包裝(模擬)
產品包裝(模擬)
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對ARO的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別ARO。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPC319Mu01 | 芳香酶(ARO)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC319Mu01 | 芳香酶(ARO)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻
| 雜志 | 參考文獻 |
| Neuroendocrinology | Neonatal Testosterone Exposure Protects Adult Male Rats from Stroke[Karger: 343804] |
| Iosr Journal Of Pharmacy | Effects of Pomegranate Seed Oil and Tamoxifen on Mastectomy Breast Cancer Women[Iosrphr: Source] |
| PLoS One. | Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.[Pubmed:25310221] |
| Gastroenterology Research | Increased Expression of Pyloric ERβ Is Associated With Diabetic Gastroparesis in Streptozotocin-Induced Male Diabetic Rats[Gastrores:701] |
| The Journal of Steroid Biochemistry and Molecular Biology | Modifications of Western-type diet regarding protein, fat and sucrose levels as modulators of steroid metabolism and activity in liver[pubmed:27471150] |
| bioorganic chemistry | 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study[Pubmed: 32247112] |
| Curr Oncol | Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer[Pubmed:35323344] |